BC
Broadfin Capital Portfolio holdings
AUM
$403M
1-Year Return
74.97%
This Quarter Return
+9.19%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$606M
AUM Growth
-$39M
(-6%)
Cap. Flow
-$47.4M
Cap. Flow
% of AUM
-7.82%
Top 10 Holdings %
Top 10 Hldgs %
55.51%
Holding
50
New
7
Increased
9
Reduced
21
Closed
6
Top Buys
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$16.2M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$12.7M |
| 3 |
Integra LifeSciences
IART
|
$12.1M |
| 4 |
MDCO
Medicines Co
MDCO
|
$10M |
| 5 |
ADMA Biologics
ADMA
|
$3.54M |
Top Sells
| 1 |
Heron Therapeutics
HRTX
|
$25.8M |
| 2 |
CORI
Corium International, Inc.
CORI
|
$9.65M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$9.19M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$8.72M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$8.01M |
Sector Composition
| 1 | Healthcare | 92.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cidara Therapeutics
CDTX
$1.6B
| $5.83M | 0.95% |
42,870
+1,850
| +5% | +$252K |
|
|
TTPH
27
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $5.6M | 0.92% |
44,455
-545
| -1% | -$68.7K |
|
28
Veracyte
VCYT
$2.55B
| $4.87M | 0.8% |
746,358
-274,474
| -27% | -$1.79M |
|
|
NUVA
29
DELISTED
NuVasive, Inc.
NUVA
| $4.8M | 0.79% |
82,100
-5,900
| -7% | -$345K |
|
|
AMRN
30
Amarin Corp
AMRN
$317M
| $4.61M | 0.75% |
57,522
-24,100
| -30% | -$1.93M |
|
|
ACGN
31
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $4.29M | 0.7% |
14,946
-2,939
| -16% | -$843K |
|
32
Baxter International
BAX
$12.5B
| $4.22M | 0.69% |
65,300
| – | – |
|
|
33
ADMA Biologics
ADMA
$4.03B
| $3.54M | 0.58% |
+1,102,200
| New | +$3.54M |
|
34
MediWound
MDWD
$177M
| $2.23M | 0.36% |
71,429
| – | – |
|
|
CGNT
35
DELISTED
Cogentix Medical, Inc.
CGNT
| $2.11M | 0.35% |
670,812
-333,540
| -33% | -$1.05M |
|
|
RGLS
36
DELISTED
Regulus Therapeutics
RGLS
| $1.57M | 0.26% |
12,578
-23,210
| -65% | -$2.9M |
|
|
CFRX
37
DELISTED
ContraFect Corporation
CFRX
| $1.24M | 0.2% |
1,540
-1,849
| -55% | -$1.49M |
|
|
AGRX
38
DELISTED
Agile Therapeutics, Inc
AGRX
| $964K | 0.16% |
+179
| New | +$964K |
|
39
Tempest Therapeutics
TPST
$48.8M
| $770K | 0.13% |
188
| – | – |
|
|
NSTG
40
DELISTED
NanoString Technologies, Inc.
NSTG
| $747K | 0.12% |
+100,000
| New | +$747K |
|
41
Vericel Corp
VCEL
$1.72B
| $472K | 0.08% |
+86,558
| New | +$472K |
|
42
Alphatec Holdings
ATEC
$2.43B
| $387K | 0.06% |
+145,514
| New | +$387K |
|
43
Strata Skin Sciences
SSKN
$7.42M
| $250K | 0.04% |
20,335
+15,552
| +325% | +$191K |
|
|
44
Alnylam Pharmaceuticals
ALNY
$59.2B
| – | – |
-74,208
| Closed | -$8.72M |
|
45
Amicus Therapeutics
FOLD
$2.46B
| – | – |
-141,000
| Closed | -$2.13M |
|
46
Owens & Minor
OMI
$434M
| – | – |
-133,700
| Closed | -$3.9M |
|
47
Zimmer Biomet
ZBH
$20.9B
| – | – |
-50,470
| Closed | -$5.74M |
|
|
AERI
48
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-64,800
| Closed | -$3.15M |
|